Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Cusan

Showing results (91-100 of 97) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 97 results.
The American Journal of Surgical Pathology|January 1, 1996
Effect of neoadjuvant endocrine therapy (combined androgen blockade) on normal prostate and prostatic carcinoma. A randomized studyL Vailancourt, B Ttu, Y Fradet, et al.
Reproduccion|October 1, 1981
Contraception with LHRH agonists, a new physiological approachF Labrie, C Séguin, A Bélanger, et al.
Progress in Clinical and Biological Research|January 1, 1981
Antifertility effects of luteinizing hormone-releasing hormone (LHRH) agonistsF Labrie, A Bélanger, P A Kelly, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|January 1, 1982
New hormonal therapy in prostatic carcinoma: combined treatment with an LHRH agonist and an antiandrogenF Labrie, A Dupont, A Belanger, et al.
Journal of Steroid Biochemistry|July 1, 1983
New hormonal treatment in cancer of the prostate: combined administration of an LHRH agonist and an antiandrogenF Labrie, A Dupont, A Belanger, et al.
Climacteric : the Journal of the International Menopause Society|January 20, 2011
Intravaginal dehydroepiandrosterone (prasterone), a highly efficient treatment of dyspareuniaF Labrie, D F Archer, C Bouchard, et al.
The Journal of Steroid Biochemistry and Molecular Biology|July 27, 1999
EM-652 (SCH 57068), a third generation SERM acting as pure antiestrogen in the mammary gland and endometriumF Labrie, C Labrie, A Bélanger, et al.
Pageof 10

Showing results (91-100 of 97) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 97 results.
The American Journal of Surgical Pathology|January 1, 1996
Effect of neoadjuvant endocrine therapy (combined androgen blockade) on normal prostate and prostatic carcinoma. A randomized studyL Vailancourt, B Ttu, Y Fradet, et al.
Reproduccion|October 1, 1981
Contraception with LHRH agonists, a new physiological approachF Labrie, C Séguin, A Bélanger, et al.
Progress in Clinical and Biological Research|January 1, 1981
Antifertility effects of luteinizing hormone-releasing hormone (LHRH) agonistsF Labrie, A Bélanger, P A Kelly, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|January 1, 1982
New hormonal therapy in prostatic carcinoma: combined treatment with an LHRH agonist and an antiandrogenF Labrie, A Dupont, A Belanger, et al.
Journal of Steroid Biochemistry|July 1, 1983
New hormonal treatment in cancer of the prostate: combined administration of an LHRH agonist and an antiandrogenF Labrie, A Dupont, A Belanger, et al.
Climacteric : the Journal of the International Menopause Society|January 20, 2011
Intravaginal dehydroepiandrosterone (prasterone), a highly efficient treatment of dyspareuniaF Labrie, D F Archer, C Bouchard, et al.
The Journal of Steroid Biochemistry and Molecular Biology|July 27, 1999
EM-652 (SCH 57068), a third generation SERM acting as pure antiestrogen in the mammary gland and endometriumF Labrie, C Labrie, A Bélanger, et al.
Pageof 10